Highest-materiality recent filing
Merlin Q1 net loss $90.4M; introduces Condor product; automated takeoffs achieved
Total revenue $1.0M (vs $0.9M Q1 2025); GAAP net loss $90.4M (vs $12.7M).
Merlin raises $80M in PIPE from existing institutional investor; pro forma cash $183M
Issued 8M shares at $10 each and warrants for 4M shares at $6.67 strike, 5-year expiry.
Merlin, Inc. completes $800M SPAC merger with Inflection Point IV; begins trading under MRLN
Closing on March 16, 2026; aggregate consideration of 75.8M shares of New Merlin Common Stock.
Shareholders approve business combination with Merlin Labs; all proposals pass
Business Combination Proposal approved: 18,540,948 FOR, 1,811,622 AGAINST, 5,531 ABSTAIN.
Merlin Labs sets March 3 investor webinar ahead of SPAC merger
Merlin Labs to host Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET.
Merlin Labs & Inflection Point upsize PIPE to >$200M, including $85M pre-funded
Existing PIPE investor increased its commitment from $50M to $100M (9.8M preferred shares).
On October 21, 2025, shareholders voted to change the company name from Bleichroeder Acquisition Corp. I to Inflection Point Acquisition Corp. IV.
Partnership to develop AI-enabled autonomy core platform for crew reduction and uncrewed flight on military and civil aircraft.
Bleichroeder Acquisition Corp. I to merge with Merlin Labs in $800M SPAC deal
Deal valued at $800M; expected close in Q1 2026 subject to shareholder and regulatory approvals.
BACQ retains MJP Advisory as consultant; $60k retainer upon BCA deal, $16k/mo
One-time retainer of $60,000 payable upon execution of a definitive business combination agreement.
Andrew Gundlach resigned as President and CEO, appointed Executive Chairman; Marcello Padula resigned as CFO.
Bleichroeder Acquisition Corp. I appoints new CFO, audit committee chair change
CFO Robert Folino resigns, effective May 7, 2025.
Bleichroeder Acquisition Corp. I announces separate trading of shares and rights from Dec 2, 2024
Holders of BACQU units may elect to separate into Class A ordinary shares and rights starting Dec 2, 2024.
Bleichroeder Acquisition Corp. I closes $250M IPO; $250M placed in trust
IPO of 25M units at $10/unit raised $250M gross; each unit includes one Class A share and one right.
Bleichroeder Acquisition Corp. I closes $250M IPO; 25M units at $10 each
IPO of 25,000,000 units at $10.00 per unit; gross proceeds $250,000,000.
Nazim Cetin resigned as the Chair of the Audit Committee effective April 8, 2025, but will continue to serve as a member of the Audit Committee.
On April 10, 2025, the Board appointed Marcello Padula to serve as the Chief Financial Officer of the Company, effective on May 7, 2025.
the Board appointed Kathy Savitt as the Chair of the Audit Committee of the Company.
On April 4, 2025, Robert Folino notified the board of directors (the “Board”) of Bleichroeder Acquisition Corp. I (the “Company”) of his resignation as Chief Financial Officer of the Company, effective on May 7, 2025.
On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Max materiality 0.90 · Median 0.60 · Most common event other_material